Lastly, T cells specific to neoantigens, melanocyte differentiation antigens or cancer germline antigens were identified in 4.7% to 43.9% of the CD8+ TILs isolated from the tumors of four melanoma patients (Section 5.4 and Section 5.5) [154]. Here, CD8A is linked to melanoma.